Life-Saving pill tested to shield children from devastating strokes

NCT ID NCT06526117

Recruiting now Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a daily oral medication called hydroxyurea can effectively prevent first strokes in children with sickle cell disease in Nigeria. It will involve 220 children aged 5-12 who are at high risk for stroke. The goal is to confirm this treatment works well in real-world clinic settings where regular blood transfusions, the standard prevention method, are not feasible.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aminu Kano Teaching Hospital
RECRUITING

Kano, Nigeria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Murtala Muhammad Specialist Hospital
RECRUITING

Kano, Nigeria

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SICKLE CELL DISEASE STROKE